Latest news for Sundance Strat (OTC:SUND) Stock

Sundance Strategies Inc is a specialty financial services company. The company is engaged in the business of purchasing or acquiring life insurance policies and residual interests in or financial products tied to life insurance policies and residual interests involving life insurance policies and financial products. It focuses on the purchase and sale of net insurance benefit contracts (NIB) based on life insurance policies.

News

Intraday Update

Markets

Movers

Trading Ideas

AFGC

AMRR

BABYF

BILI

CODX

EVBG

FTSV

IBDSF

INSP

INSU

JSTTY

KNSL

LAKE

LONCF

MJDS

MRNA

NIOCF

NVRO

OCQLF

QMXGF

RGDEF

SMED

SUND

VNET

WDFN

XFLS

VSTKF

ELMD

MDSQF

Stocks That Hit 52-Week Highs On Wednesday

SUNDANCE STRATEGIES INC by Sundance Strategies Inc.

Sundance Strategies Inc

SUNDART HLDGS LTD by SUNDART HLDGS LTD

Sundrug Co Ltd

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

BJDX

SMST

LIFW

SMCX

LIFWW

Numinus Wellness Inc. (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/NUMIF#OTCQX">NUMIF</a>), a leader in <a href="https://www.benzinga.com/topic/psychedelic-assisted-therapies">psychedelic-assisted mental health care</a>, has <a href="https://www.investors.numinus.com/news/news-details/2024/Numinus-Wellness-Announces-Sale-of-Clinics-and-Unique-Data-Partnership-to-Increase-Access-to-Mental-Health-Care/default.aspx">announced</a> a definitive agreement with Stella, an interventional psychiatry practice, to sell its five wellness clinics in Utah for a total of $3.53 million. The transaction, expected to close by November 30, marks a strategic shift for Numinus, as it pivots towards <a href="https://www.benzinga.com/markets/cannabis/24/09/40845569/mdma-therapy-for-ptsd-faces-fda-delay-are-there-other-ways-forward">developing technology-driven solutions</a> aimed at enhancing the efficiency of mental health care providers.
<h3 class="wp-block-heading">Tech Partnership To Redefine Mental Health Clinics</h3>
In addition to the sale, Numinus and Stella will collaborate on a data-sharing initiative to launch an innovative clinic management platform. By leveraging operational insights from Stella's 12 clinics, Numinus plans to develop a software solution designed to streamline clinic operations, enhance patient outcomes and support insurance reimbursement processes.
"This transaction marks an exciting new chapter in Numinus' strategy to reshape behavioral health care," said Payton Nyquvest, founder and CEO of Numinus. "Leveraging our expertise in patient care, we're now accelerating our mission by focusing on cutting-edge technology solutions. Through our partnership with Stella, we gain unprecedented access to operational data that will enable us to develop a SaaS (software as a service) solution to redefine how clinics operate."
<h3 class="wp-block-heading">Stella Takes Over Utah Operations</h3>
Stella, known for its focus on treating PTSD, anxiety and depression through biological modalities, will assume control of Numinus' Utah clinics. The acquisition includes an upfront payment of $2.08 million, followed by $750,000 in installments throughout 2025, and up to $700,000 in deferred compensation.
"Stella's expansion into Utah brings additional life-changing treatments to the community while supporting Numinus' broader tech initiatives," stated Michael Gershenzon, co-founder and CEO of Stella. "This partnership reflects our commitment to improving behavioral health systems and processes, ultimately enhancing patient care."
<h3 class="wp-block-heading">An Asset-Light Business Model With Enhanced Focus</h3>
With the sale of its clinics, Numinus will shift towards an asset-light model, focusing on its business units like Cedar Clinical Research and the Numinus Network. The strategy aims to integrate clinical research, practitioner training and technology solutions, supporting mental health providers worldwide. The move is part of a broader effort to ease the operational burdens faced by healthcare professionals, particularly as demand for treatments like <a href="https://www.benzinga.com/topic/ketamine-therapy">ketamine</a> and Spravato continues to rise.
"Stella will bolster our clinical solutions offering, leveraging their deep expertise in patient care," Nyquvest added. "We expect strong demand for our Numinus Network Solutions as mental health practitioners navigate growing requests for care."
Cover image made with AI

Cannabis

Psychedelics

NUMIF

Numinus Wellness Sells US Clinics, Partners With Stella For Tech-Driven Mental Health Solutions

President-elect Donald Trump has chosen former Representative Doug Collins (R-GA) to lead the <a href="https://www.benzinga.com/cannabis">U.S. Department of Veterans Affairs (VA). </a>
The decision has sparked discussions about how the agency might handle medical cannabis issues, given his inconsistent track record on the issue, as <a href="https://www.marijuanamoment.net/trumps-pick-to-lead-va-voted-against-letting-agency-doctors-recommend-medical-marijuana-to-veterans-before-he-adopted-a-pro-reform-position/">reported</a> Marijuana Moment.
<h3 class="wp-block-heading">Collins' Record On Cannabis</h3>
During his time in Congress, Collins opposed efforts to expand access to medical cannabis for veterans. Between 2014 and 2016, he voted against three proposals that would have allowed VA doctors to recommend cannabis to their patients.
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/11/42018478/trumps-cabinet-choices-will-his-administration-support-or-restrict-cannabis">Trump&#8217;s Cabinet Choices: Will His Administration Support Or Restrict Cannabis?</a>
Collins' views began to shift in 2019. He supported the STATES Act, which would protect state marijuana programs from federal interference, and co-signed a letter with Rep. Matt Gaetz (R-FL), urging Congress to take action on cannabis policy. 
"We believe this Committee and this Congress must act to clarify the rights and responsibilities, relative to cannabis, of individuals, physicians, businesses, medical patients, and law enforcement officials," they wrote.
Later that year, Collins backed a bipartisan bill to protect banks that serve marijuana businesses in states where it is legal. However, he did not take part in a 2020 vote on federal cannabis legalization.
<h3 class="wp-block-heading">Collins' Stance On Psychedelics</h3>
When it comes to psychedelics, there isn't much known about Collins's stance. However, his shifting views on cannabis policy hint that he could be open to exploring different approaches.
<h3 class="wp-block-heading">Cannabis At The VA</h3>
VA policy has long prohibited its doctors from recommending cannabis, citing marijuana's classification as a Schedule I controlled substance under federal law. This stance has remained consistent across both Republican and Democratic administrations, despite growing support for change in Congress.
Recent efforts to address this issue include a Senate Appropriations Committee request for the VA to explore cannabis as an alternative to opioids. Lawmakers have also introduced measures that would allow VA doctors to recommend cannabis in states where it is legal. These efforts have gained bipartisan support, but none have yet become law.
Veterans service organizations have pushed for further reforms, including expanded research into the potential benefits of cannabis. Last year, a Senate committee approved a bill to study cannabis for veterans with certain medical conditions, but it failed to advance to a floor vote.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/health-care/24/11/42017583/trumps-go-wild-on-health-plan-puts-rfk-jr-in-charge-what-it-means-for-cannabis-and-psychedelics-reform">Trump&#8217;s &#8216;Go Wild On Health&#8217; Plan Puts RFK Jr. In Charge: What It Means For Cannabis And Psychedelics Reform</a></li>
</ul>
Cover image made with AI.

Government

Politics

Trump-Appointed Doug Collins To Lead VA: What's Next For Cannabis and Psychedelics In Veterans' Healthcare?

Chardan Capital analyst Daniil Gataulin maintains Clearside Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSD#NASDAQ">CLSD</a>) with a Buy and maintains $6 price target.

Price Target

Analyst Ratings

CLSD

Chardan Capital Maintains Buy on Clearside Biomedical, Maintains $6 Price Target

Chardan Capital analyst Daniil Gataulin maintains Cognition Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTX#NASDAQ">CGTX</a>) with a Buy and maintains $11 price target.

CGTX

Chardan Capital Maintains Buy on Cognition Therapeutics, Maintains $11 Price Target

Telsey Advisory Group analyst Cristina Fernandez maintains Williams-Sonoma (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) with a Outperform and maintains $165 price target.

Telsey Advisory Group Maintains Outperform on Williams-Sonoma, Maintains $165 Price Target

– Approval based on positive data from the AUGMENT-101 clinical trial, in which Revuforj delivered robust and durable rates of remission in R/R acute leukemia patients with a KMT2A translocation –
– Syndax to host conference call today at 6:00 p.m. ET –
WALTHAM, Mass., Nov. 15, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDX#NASDAQ">SNDX</a>) today announced that the U.S. Food and Drug Administration (FDA) has approved Revuforj&#xAE; (revumenib) as the first and only menin inhibitor for the treatment of relapsed or refractory (R/R) acute leukemia with a lysine methyltransferase 2A gene (KMT2A) translocation in adult and pediatric patients one year and older. The FDA previously granted Breakthrough Therapy and Fast Track designations as well as Priority Review for Revuforj. The New Drug Application (NDA) received approval through the FDA's Real Time Oncology Review (RTOR) program.

Biotech

General

SNDX

Syndax Announces FDA Approval Of Revuforj, The First And Only Menin Inhibitor To Treat Adult And Pediatric Patients With Relapsed Or Refractory Acute Leukemia With A KMT2A Translocation

IT Tech Packaging (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ITP#AMEX">ITP</a>) reported quarterly losses of $(0.20) per share. This is unchanged from the same period last year. The company reported $25.08 million in sales this quarter. This is a 59.03 percent increase over sales of $15.77 million the same period last year.

Earnings

IT Tech Packaging Q3 EPS $(0.20), Same YoY, Sales $25.08M Up From $15.77M YoY

RumbleOn, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBL#NASDAQ">RMBL</a>) (the "Company" or "RumbleOn") announced today that the close of business (4:00 p.m. Central Time) on November 25, 2024 has been fixed as the record date (the "Record Date") for its previously announced proposed $10.0 million registered equity rights offering (the "Rights Offering"), which was announced in a Form 8-K filed with the U.S. Securities and Exchange Commission ("SEC") on November 12, 2024.

Offerings

RMBL

RumbleOn Announces That The Close Of Business On November 25, 2024 Has Been Fixed As The Record Date For Its Previously Announced Proposed $10M Registered Equity Rights Offering

Telsey Advisory Group analyst Dana Telsey maintains European Wax Center (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWCZ#NASDAQ">EWCZ</a>) with a Outperform and maintains $8 price target.

EWCZ

Telsey Advisory Group Maintains Outperform on European Wax Center, Maintains $8 Price Target

<a href="https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20241115-1475367/1475367_4rcm.pdf" title="https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20241115-1475367/1475367_4rcm.pdf">https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20241115-1475367/1475367_4rcm.pdf</a>

FOUR

Shift4 Payments Will Replace R1 RCM In The S&P Midcap 400 Effective Prior To The Opening Of Trading On Wednesday, November 20

China Green Agriculture, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CGA#NYSE">CGA</a>) has changed its name to Enlightify Inc., effective November 25, 2024. Its ticker symbol will change to ENFY effective November 25, 2024, and it is expected to begin trading under that symbol on November 26, 2024. The Company mainly produces and distributes humic acid-based compound fertilizers, other varieties of compound fertilizers and agricultural products through its subsidiaries in China.

China Green Agriculture Changes Name to Enlightify Inc.; Its Ticker Symbol Will Change To 'ENFY' Effective November 25, 2024, And It Is Expected To Begin Trading Under That Symbol On November 26, 2024

Alpha Cognition (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACOG#NASDAQ">ACOG</a>) reported quarterly losses of $(0.31) per share. This is a 63.1 percent increase over losses of $(0.84) per share from the same period last year.

ACOG

Alpha Cognition Q2 EPS $(0.31) Up From $(0.84) YoY

D. Boral Capital analyst Jason Kolbert maintains NRX Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRXP#NASDAQ">NRXP</a>) with a Buy and maintains $31 price target.

NRXP

D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $31 Price Target

D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VNRX#AMEX">VNRX</a>) with a Buy and maintains $5 price target.

VNRX

D. Boral Capital Maintains Buy on VolitionRX, Maintains $5 Price Target

Sundance Strat

This morning 44 companies set new 52-week highs.

<h3>Interesting Points:</h3>

<ul>
	<li>The largest company by market cap to break to a new 52-week high was&nbsp;TJX Companies&nbsp;(NYSE:<a class="ticker" href="/stock/TJX#NYSE">TJX</a>).</li>
	<li>The smallest company when looking at market cap to set a new 52-week high was&nbsp;XFuels&nbsp;(OTC:<a class="ticker" href="/stock/XFLS#OTC">XFLS</a>).</li>
	<li>Niocan&nbsp;(OTC:<a class="ticker" href="/stock/NIOCF#OTC">NIOCF</a>)&nbsp;shares suffered the most, as they hit a 52-week high but moved 5.86% down thereafter.</li>
</ul>

Stocks breaking to new 52-week highs as of 10 a.m. ET on Wednesday:

<ul>
	<li>TJX Companies&nbsp;(NYSE:<a class="ticker" href="/stock/TJX#NYSE">TJX</a>)&nbsp;shares achieved a new 52-week high on Wednesday morning, hitting $64.51 with a daily change of up 7.37%.</li>
	<li>Iberdrola&nbsp;(OTC:<a class="ticker" href="/stock/IBDSF#OTC">IBDSF</a>)&nbsp;shares were up 4.48% on Wednesday morning to hit a new 52-week high of $11.97.</li>
	<li>Alcon&nbsp;(NYSE:<a class="ticker" href="/stock/ALC#NYSE">ALC</a>)&nbsp;shares set a new 52-week high of $64.23 on Wednesday, moving up 7.58%.</li>
	<li>Just Eat&nbsp;(OTC:<a class="ticker" href="/stock/JSTTY#OTC">JSTTY</a>)&nbsp;shares were up 15.3% for the day, having made a 52-week high of $15.00.</li>
	<li>Bilibili&nbsp;(NASDAQ:<a class="ticker" href="/stock/BILI#NASDAQ">BILI</a>)&nbsp;shares hit a yearly high of $29.05. The stock traded up 7.56% on the session.</li>
	<li>Moderna&nbsp;(NASDAQ:<a class="ticker" href="/stock/MRNA#NASDAQ">MRNA</a>)&nbsp;shares set a new 52-week high of $29.80 on Wednesday, moving up 16.33%.</li>
	<li>Vostok New Ventures&nbsp;(OTC:<a class="ticker" href="/stock/VSTKF#OTC">VSTKF</a>)&nbsp;stock on Wednesday broke to a yearly high of $7.45. Shares traded up 4.2%.</li>
	<li>Nevro&nbsp;(NYSE:<a class="ticker" href="/stock/NVRO#NYSE">NVRO</a>)&nbsp;shares set a new 52-week high of $145.85 on Wednesday, moving up 9.99%.</li>
	<li>Everbridge&nbsp;(NASDAQ:<a class="ticker" href="/stock/EVBG#NASDAQ">EVBG</a>)&nbsp;shares set a new 52-week high of $106.97 on Wednesday, moving up 2.16%.</li>
	<li>National Vision Holdings&nbsp;(NASDAQ:<a class="ticker" href="/stock/EYE#NASDAQ">EYE</a>)&nbsp;shares broke to a new 52-week high of $38.69 on Wednesday. Shares of the company traded up 13.51%.</li>
	<li>Kinsale Capital Group&nbsp;(NASDAQ:<a class="ticker" href="/stock/KNSL#NASDAQ">KNSL</a>)&nbsp;shares hit a new 52-week high of $131.41. The stock traded up 0.41% on the session.</li>
	<li>Forty Seven&nbsp;(NASDAQ:<a class="ticker" href="/stock/FTSV#NASDAQ">FTSV</a>)&nbsp;shares broke to a new 52-week high of $50.00 on Wednesday. Shares of the company traded down 1.65%.</li>
	<li>Inspire Medical Systems&nbsp;(NYSE:<a class="ticker" href="/stock/INSP#NYSE">INSP</a>)&nbsp;stock hit a yearly high price of $84.30. The stock was up 10.03% for the day.</li>
	<li>21Vianet Group&nbsp;(NASDAQ:<a class="ticker" href="/stock/VNET#NASDAQ">VNET</a>)&nbsp;shares hit a new 52-week high of $15.65. The stock traded up 2.14% on the session.</li>
	<li>HeadHunter Group&nbsp;(NASDAQ:<a class="ticker" href="/stock/HHR#NASDAQ">HHR</a>)&nbsp;shares set a new 52-week high of $26.88 on Wednesday, moving up 1.19%.</li>
	<li>BLACKROCK MUNIYIELD&nbsp;(NYSE:<a class="ticker" href="/stock/MYI#NYSE">MYI</a>)&nbsp;shares were up 0.14% on Wednesday morning to hit a new 52-week high of $14.20.</li>
	<li>Putnam Managed Municipal&nbsp;(NYSE:<a class="ticker" href="/stock/PMM#NYSE">PMM</a>)&nbsp;stock on Wednesday broke to a yearly high of $8.43. Shares traded flat%.</li>
	<li>Nuveen Enhanced Municipal&nbsp;(NYSE:<a class="ticker" href="/stock/NEV#NYSE">NEV</a>)&nbsp;shares reached a new 52-week high of $15.90 on Wednesday morning, moving up 0.57%.</li>
	<li>Neuberger Berman&nbsp;(AMEX:<a class="ticker" href="/stock/NBH#AMEX">NBH</a>)&nbsp;shares were up 1.59% on Wednesday morning to hit a new 52-week high of $16.82.</li>
	<li>Insurance Acquisition&nbsp;(NASDAQ:<a class="ticker" href="/stock/INSU#NASDAQ">INSU</a>)&nbsp;shares achieved a new 52-week high on Wednesday morning, hitting $10.16 with a daily change of flat%.</li>
	<li>China Online Education Gr&nbsp;(NYSE:<a class="ticker" href="/stock/COE#NYSE">COE</a>)&nbsp;stock made a new 52-week high of $31.30 Wednesday. The stock was up 12.91% for the day.</li>
	<li>Blackrock Muniyield Inv&nbsp;(NYSE:<a class="ticker" href="/stock/MYF#NYSE">MYF</a>)&nbsp;shares set a new yearly high of $15.30 this morning. The stock was up 0.43% on the session.</li>
	<li>BNY Mellon Municipal&nbsp;(AMEX:<a class="ticker" href="/stock/DMF#AMEX">DMF</a>)&nbsp;shares achieved a new 52-week high on Wednesday morning, hitting $9.77 with a daily change of down 0.06%.</li>
	<li>Federated Premier&nbsp;(NYSE:<a class="ticker" href="/stock/FMN#NYSE">FMN</a>)&nbsp;stock on Wednesday broke to a yearly high of $14.79. Shares traded up 0.1%.</li>
	<li>Sundance Strategies&nbsp;(OTC:<a class="ticker" href="/stock/SUND#OTC">SUND</a>)&nbsp;stock hit a yearly high price of $3.25. The stock was down 5.86% for the day.</li>
	<li>Blackrock Strategic&nbsp;(NYSE:<a class="ticker" href="/stock/BSD#NYSE">BSD</a>)&nbsp;shares were up 0.92% for the day, having made a 52-week high of $15.28.</li>
	<li>Lakeland Industries&nbsp;(NASDAQ:<a class="ticker" href="/stock/LAKE#NASDAQ">LAKE</a>)&nbsp;shares were up 8.89% on Wednesday to hit a new 52-week high of $16.48 for a change of up 8.89%.</li>
	<li>Electromed&nbsp;(AMEX:<a class="ticker" href="/stock/ELMD#AMEX">ELMD</a>)&nbsp;shares achieved a new 52-week high on Wednesday morning, hitting $13.33 with a daily change of up 3.42%.</li>
	<li>Sharps Compliance&nbsp;(NASDAQ:<a class="ticker" href="/stock/SMED#NASDAQ">SMED</a>)&nbsp;shares achieved a new 52-week high on Wednesday morning, hitting $6.00 with a daily change of up 1.53%.</li>
	<li>Co-Diagnostics&nbsp;(NASDAQ:<a class="ticker" href="/stock/CODX#NASDAQ">CODX</a>)&nbsp;shares set a new yearly high of $4.61 this morning. The stock was up 15.3% on the session.</li>
	<li>Woodlands Financial Servs&nbsp;(OTC:<a class="ticker" href="/stock/WDFN#OTC">WDFN</a>)&nbsp;shares broke to $37.00 on Wednesday, setting a new 52-week high with a change of up 5.71%.</li>
	<li>Alpha Pro Tech&nbsp;(AMEX:<a class="ticker" href="/stock/APT#AMEX">APT</a>)&nbsp;shares set a new 52-week high of $10.81 on Wednesday, moving up 22.08%.</li>
	<li>Else Nutrition Holdings&nbsp;(OTC:<a class="ticker" href="/stock/BABYF#OTC">BABYF</a>)&nbsp;shares hit $1.03 on Wednesday morning, setting a new 52-week high for a change of up 2.3%.</li>
	<li>Loncor Resources&nbsp;(OTC:<a class="ticker" href="/stock/LONCF#OTC">LONCF</a>)&nbsp;shares hit a new 52-week high of $0.56. The stock traded up 6.13% on the session.</li>
	<li>QMX Gold&nbsp;(OTC:<a class="ticker" href="/stock/QMXGF#OTC">QMXGF</a>)&nbsp;shares reached a new 52-week high of $0.11 on Wednesday morning, moving up 6.73%.</li>
	<li>Power REIT&nbsp;(AMEX:<a class="ticker" href="/stock/PW#AMEX">PW</a>)&nbsp;shares achieved a new 52-week high on Wednesday morning, hitting $15.60 with a daily change of up 0.72%.</li>
	<li>01 Communique Laboratory&nbsp;(OTC:<a class="ticker" href="/stock/OCQLF#OTC">OCQLF</a>)&nbsp;shares reached a new 52-week high of $0.14 on Wednesday morning, moving up 140.86%.</li>
	<li>Minsud Resources&nbsp;(OTC:<a class="ticker" href="/stock/MDSQF#OTC">MDSQF</a>)&nbsp;stock set a new 52-week high of $0.06 Wednesday morning. Over the session, the stock traded up 50.0%.</li>
	<li>Niocan&nbsp;(OTC:<a class="ticker" href="/stock/NIOCF#OTC">NIOCF</a>)&nbsp;shares set a new 52-week high of $0.20 on Wednesday, moving up 54.39%.</li>
	<li>Africa Growth&nbsp;(NYSE:<a class="ticker" href="/stock/AFGC#NYSE">AFGC</a>)&nbsp;shares were up 0.51% on Wednesday morning to hit a new 52-week high of $26.22.</li>
	<li>MOJO Data Solutions&nbsp;(OTC:<a class="ticker" href="/stock/MJDS#OTC">MJDS</a>)&nbsp;shares achieved a new 52-week high on Wednesday morning, hitting $0.10 with a daily change of up 5.0%.</li>
	<li>American Metals Recovery&nbsp;(OTC:<a class="ticker" href="/stock/AMRR#OTC">AMRR</a>)&nbsp;shares broke to $0.46 on Wednesday, setting a new 52-week high with a change of up 63.87%.</li>
	<li>RDX Technologies&nbsp;(OTC:<a class="ticker" href="/stock/RGDEF#OTC">RGDEF</a>)&nbsp;shares hit $0.14 on Wednesday morning, setting a new 52-week high for a change of flat%.</li>
	<li>XFuels&nbsp;(OTC:<a class="ticker" href="/stock/XFLS#OTC">XFLS</a>)&nbsp;shares hit a yearly high of $0.02. The stock traded up 5.56% on the session.</li>
</ul>

 
Benzinga will continue to update investors on these equities. Stay tuned for further news.

Comments

Sundance Strat

News

Latest news for Sundance Strat (OTC:SUND) Stock

Wednesday, February 26, 2020

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga